Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 178

1.

MRI guided iron assessment and oral chelator use improve iron status in thalassemia major patients.

Nichols-Vinueza DX, White MT, Powell AJ, Banka P, Neufeld EJ.

Am J Hematol. 2014 Jul;89(7):684-8. doi: 10.1002/ajh.23715. Epub 2014 Apr 10.

2.
3.

Correlative study of iron accumulation in liver, myocardium, and pituitary assessed with MRI in young thalassemic patients.

Christoforidis A, Haritandi A, Tsitouridis I, Tsatra I, Tsantali H, Karyda S, Dimitriadis AS, Athanassiou-Metaxa M.

J Pediatr Hematol Oncol. 2006 May;28(5):311-5.

PMID:
16772883
4.

Deferasirox (Exjade) significantly improves cardiac T2* in heavily iron-overloaded patients with beta-thalassemia major.

Pathare A, Taher A, Daar S.

Ann Hematol. 2010 Apr;89(4):405-9. doi: 10.1007/s00277-009-0838-z. Epub 2009 Oct 2.

5.

Efficacy and safety of deferasirox, an oral iron chelator, in heavily iron-overloaded patients with beta-thalassaemia: the ESCALATOR study.

Taher A, El-Beshlawy A, Elalfy MS, Al Zir K, Daar S, Habr D, Kriemler-Krahn U, Hmissi A, Al Jefri A.

Eur J Haematol. 2009 Jun;82(6):458-65. doi: 10.1111/j.1600-0609.2009.01228.x. Epub 2009 Jan 28.

6.

Liver iron content assessment by routine and simple magnetic resonance imaging procedure in highly transfused patients.

Rose C, Vandevenne P, Bourgeois E, Cambier N, Ernst O.

Eur J Haematol. 2006 Aug;77(2):145-9. Epub 2006 Apr 11.

PMID:
16608501
7.

Myocardial and liver iron overload, assessed using T2* magnetic resonance imaging with an excel spreadsheet for post processing in Tunisian thalassemia major patients.

Ouederni M, Ben Khaled M, Mellouli F, Ben Fraj E, Dhouib N, Yakoub IB, Abbes S, Mnif N, Bejaoui M.

Ann Hematol. 2017 Jan;96(1):133-139. doi: 10.1007/s00277-016-2841-5. Epub 2016 Oct 12.

PMID:
27730342
8.

A practical chelation protocol based on stratification of thalassemic patients by serum ferritin and magnetic resonance imaging cardiac T2*.

Ha SY, Mok AS, Chu WC, Raskalkar DD, Cheuk DK, Chiang AK, Ho MH, Chan GC.

Hemoglobin. 2009;33(5):323-31. doi: 10.3109/03630260903211979.

PMID:
19814678
9.

Efficacy and safety of deferasirox at low and high iron burdens: results from the EPIC magnetic resonance imaging substudy.

Porter JB, Elalfy MS, Taher AT, Aydinok Y, Chan LL, Lee SH, Sutcharitchan P, Habr D, Martin N, El-Beshlawy A.

Ann Hematol. 2013 Jan;92(2):211-9. doi: 10.1007/s00277-012-1588-x. Epub 2012 Oct 21.

10.

A 5-year follow-up in deferasirox treatment: improvement of cardiac and hepatic iron overload and amelioration in cardiac function in thalassemia major patients.

Cassinerio E, Roghi A, Orofino N, Pedrotti P, Zanaboni L, Poggiali E, Giuditta M, Consonni D, Cappellini MD.

Ann Hematol. 2015 Jun;94(6):939-45. doi: 10.1007/s00277-014-2291-x. Epub 2015 Jan 8.

PMID:
25563596
11.

[Value of magnetic resonance imaging T2* tests in detecting heart and liver iron overload in patients with β-thalassemia major].

Wu X, Jing Y, Pei F, Chen J, Feng X, He Y, Zhang Y, Li C.

Nan Fang Yi Ke Da Xue Xue Bao. 2013 Feb;33(2):249-52. Chinese.

12.

Pituitary iron and volume predict hypogonadism in transfusional iron overload.

Noetzli LJ, Panigrahy A, Mittelman SD, Hyderi A, Dongelyan A, Coates TD, Wood JC.

Am J Hematol. 2012 Feb;87(2):167-71. doi: 10.1002/ajh.22247. Epub 2011 Dec 27.

13.

Multicenter validation of spin-density projection-assisted R2-MRI for the noninvasive measurement of liver iron concentration.

St Pierre TG, El-Beshlawy A, Elalfy M, Al Jefri A, Al Zir K, Daar S, Habr D, Kriemler-Krahn U, Taher A.

Magn Reson Med. 2014 Jun;71(6):2215-23. doi: 10.1002/mrm.24854. Epub 2013 Jul 2.

14.
15.

The effect of deferasirox on cardiac iron in thalassemia major: impact of total body iron stores.

Wood JC, Kang BP, Thompson A, Giardina P, Harmatz P, Glynos T, Paley C, Coates TD.

Blood. 2010 Jul 29;116(4):537-43. doi: 10.1182/blood-2009-11-250308. Epub 2010 Apr 26.

16.

Efficacy and safety of deferasirox in β-thalassemia major patients in Iran: a prospective study from a single referral center in Iran.

Alavi S, Ebadi M, Ghazizadeh F, Arzanian MT, Shamsian B, Abdollah Gorji F.

Pediatr Hematol Oncol. 2014 Feb;31(1):76-86. doi: 10.3109/08880018.2013.861046. Epub 2014 Jan 2.

PMID:
24383712
19.

Multiparametric Cardiac Magnetic Resonance Survey in Children With Thalassemia Major: A Multicenter Study.

Casale M, Meloni A, Filosa A, Cuccia L, Caruso V, Palazzi G, Gamberini MR, Pitrolo L, Putti MC, D'Ascola DG, Casini T, Quarta A, Maggio A, Neri MG, Positano V, Salvatori C, Toia P, Valeri G, Midiri M, Pepe A.

Circ Cardiovasc Imaging. 2015 Aug;8(8):e003230. doi: 10.1161/CIRCIMAGING.115.003230.

20.

Effects of combined deferiprone and deferoxamine chelation therapy on iron load indices in beta-thalassemia.

Tsironi M, Assimakopoulos G, Polonofi K, Rigaki K, Aessopos A.

Hemoglobin. 2008;32(1-2):29-34. doi: 10.1080/03630260701680474.

PMID:
18274980

Supplemental Content

Support Center